This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 Jun 2;48(11):3663-79.

doi: 10.1021/jm040190e.

Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents

Amy Hauck Newman¹, Peter Grundt, Michael A Nader

Affiliations

Affiliation

¹ National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, 5500 Nathan Shock Drive, Baltimore, Maryland 21224, USA. anewman@intra.nida.nih.gov

PMID: 15916415
DOI: 10.1021/jm040190e

Review

Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents

Amy Hauck Newman et al. J Med Chem. 2005.

. 2005 Jun 2;48(11):3663-79.

doi: 10.1021/jm040190e.

Authors

Amy Hauck Newman¹, Peter Grundt, Michael A Nader

Affiliation

¹ National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, 5500 Nathan Shock Drive, Baltimore, Maryland 21224, USA. anewman@intra.nida.nih.gov

PMID: 15916415
DOI: 10.1021/jm040190e

No abstract available

PubMed Disclaimer

Similar articles

Role of dopamine D3 receptors in controlling the expression of cocaine sensitization in rats.
Filip M, Papla I, Czepiel K. Filip M, et al. Pol J Pharmacol. 2002 Nov-Dec;54(6):687-91. Pol J Pharmacol. 2002. PMID: 12866725
The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure.
Holmes IP, Blunt RJ, Lorthioir OE, Blowers SM, Gribble A, Payne AH, Stansfield IG, Wood M, Woollard PM, Reavill C, Howes CM, Micheli F, Di Fabio R, Donati D, Terreni S, Hamprecht D, Arista L, Worby A, Watson SP. Holmes IP, et al. Bioorg Med Chem Lett. 2010 Mar 15;20(6):2013-6. doi: 10.1016/j.bmcl.2010.01.090. Epub 2010 Jan 25. Bioorg Med Chem Lett. 2010. PMID: 20153647
[Functional role of dopamine D3 receptor in schizophrenia].
Semba J. Semba J. Nihon Shinkei Seishin Yakurigaku Zasshi. 2004 Feb;24(1):3-11. Nihon Shinkei Seishin Yakurigaku Zasshi. 2004. PMID: 15027325 Review. Japanese.
Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
Depoortère R, Bardin L, Rodrigues M, Abrial E, Aliaga M, Newman-Tancredi A. Depoortère R, et al. Behav Pharmacol. 2009 Jul;20(4):303-11. doi: 10.1097/FBP.0b013e32832ec5aa. Behav Pharmacol. 2009. PMID: 19584712
Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.
Zhang A, Neumeyer JL, Baldessarini RJ. Zhang A, et al. Chem Rev. 2007 Jan;107(1):274-302. doi: 10.1021/cr050263h. Chem Rev. 2007. PMID: 17212477 Review. No abstract available.

See all similar articles

Cited by

Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR.
Grundt P, Husband SL, Luedtke RR, Taylor M, Newman AH. Grundt P, et al. Bioorg Med Chem Lett. 2007 Feb 1;17(3):745-9. doi: 10.1016/j.bmcl.2006.10.076. Epub 2006 Oct 28. Bioorg Med Chem Lett. 2007. PMID: 17095222 Free PMC article.
Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.
Collins GT, France CP. Collins GT, et al. Exp Clin Psychopharmacol. 2018 Oct;26(5):488-496. doi: 10.1037/pha0000209. Epub 2018 Jun 28. Exp Clin Psychopharmacol. 2018. PMID: 29952618 Free PMC article.
Topiramate does not alter nicotine or cocaine discrimination in rats.
Le Foll B, Justinova Z, Wertheim CE, Barnes C, Goldberg SR. Le Foll B, et al. Behav Pharmacol. 2008 Feb;19(1):13-20. doi: 10.1097/FBP.0b013e3282f3cf84. Behav Pharmacol. 2008. PMID: 18195590 Free PMC article.
Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases.
Maramai S, Gemma S, Brogi S, Campiani G, Butini S, Stark H, Brindisi M. Maramai S, et al. Front Neurosci. 2016 Oct 5;10:451. doi: 10.3389/fnins.2016.00451. eCollection 2016. Front Neurosci. 2016. PMID: 27761108 Free PMC article. Review.
Fos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaine.
Nolan BC, Liu S, Hammerslag LR, Cheung TH, Lenz J, Mach RH, Luedtke RR, Neisewander JL. Nolan BC, et al. Synapse. 2013 Dec;67(12):847-55. doi: 10.1002/syn.21691. Epub 2013 Jul 17. Synapse. 2013. PMID: 23766142 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- American Chemical Society
Other Literature Sources
- The Lens - Patent Citations Database
Chemical Information
- BindingDB
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information